Neoplasia — MCQs

Neoplasia Indian Medical PG Practice Questions and MCQs

Question 621: Which of the following is an example of transplacental carcinogenesis?

A. Vaginal carcinoma (Correct Answer)
B. Pancreatic carcinoma
C. Colon carcinoma
D. Breast cancer

Explanation: **Explanation:** **Transplacental carcinogenesis** refers to the induction of cancer in the offspring due to exposure of the pregnant mother to a carcinogen [1]. The classic medical example of this phenomenon is the development of **Clear Cell Adenocarcinoma of the Vagina** in young women whose mothers were prescribed **Diethylstilbestrol (DES)** during pregnancy [1]. 1. **Why Vaginal Carcinoma is Correct:** Between the 1940s and 1970s, DES (a synthetic estrogen) was used to prevent miscarriages [1]. It was later discovered that female fetuses exposed to DES in utero had a significantly higher risk of developing **Vaginal Adenosis** and, subsequently, **Clear Cell Adenocarcinoma** of the vagina and cervix in their late teens or early twenties [1]. This remains the most high-yield example of transplacental chemical carcinogenesis in pathology [1]. 2. **Why Other Options are Incorrect:** * **Pancreatic, Colon, and Breast Carcinoma:** These are primarily associated with somatic mutations, environmental factors (smoking, diet), or hereditary germline mutations (e.g., *BRCA1/2* for breast, *APC* for colon). While there is a genetic predisposition, they are not classically linked to specific in-utero chemical exposures that manifest as cancer in the offspring. **High-Yield Clinical Pearls for NEET-PG:** * **DES Exposure Effects:** In addition to Clear Cell Adenocarcinoma, it is associated with a **T-shaped uterus** and infertility in females. * **Vaginal Adenosis:** This is the precursor lesion where glandular (columnar) epithelium persists in the vagina instead of being replaced by squamous epithelium. * **Other Transplacental Risks:** While DES is the classic chemical example, certain infections (TORCH) and ionizing radiation are also potent teratogens/carcinogens during fetal development. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 223-224.

Question 622: According to WHO classification, which of the following is a nerve sheath tumor?

A. Schwannoma (Correct Answer)
B. Paraganglioma
C. Medulloblastoma
D. Astrocytoma

Explanation: **Explanation:** The correct answer is **Schwannoma**. According to the WHO classification of Central Nervous System (CNS) tumors, nerve sheath tumors originate from the supporting cells of the peripheral nerves, primarily Schwann cells [2]. **Why Schwannoma is correct:** Schwannomas are benign, encapsulated tumors arising directly from **Schwann cells**. Histologically, they are characterized by two distinct patterns: **Antoni A** (hypercellular areas with Verocay bodies) and **Antoni B** (hypocellular, myxoid areas) [3]. They are typically S100 positive. **Analysis of Incorrect Options:** * **Paraganglioma:** These are neuroendocrine tumors arising from extra-adrenal chromaffin cells (paraganglia) of the autonomic nervous system, not the nerve sheath. * **Medulloblastoma:** This is a highly malignant **embryonal tumor** arising from the cerebellum (primitive neuroectodermal cells). It is a Grade 4 WHO tumor commonly seen in children. * **Astrocytoma:** These are **gliomas** originating from astrocytes (glial cells) within the brain parenchyma, not from the peripheral nerve sheath [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Bilateral Acoustic Neuromas (Schwannomas):** Pathognomonic for **Neurofibromatosis Type 2 (NF2)** [1]. * **Verocay Bodies:** Formed by palisading nuclei surrounding fibrillary processes in Antoni A areas [3]. * **Most common site:** The vestibular branch of the 8th cranial nerve (Vestibular Schwannoma) [1]. * **Neurofibroma vs. Schwannoma:** Unlike Schwannomas, Neurofibromas are not encapsulated and are "traversed" by the nerve rather than being attached to its side. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 727-728. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1248-1249. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, p. 1250.

Question 623: Beta-2 microglobulin is used as a tumor marker for which of the following diseases?

A. Multiple myeloma (Correct Answer)
B. Acute lymphoblastic leukemia
C. Hairy cell leukemia
D. Lymphoplasmacytic lymphoma

Explanation: **Explanation:** **Beta-2 microglobulin (β2M)** is a low-molecular-weight protein that forms the light chain component of the **MHC Class I molecule**, found on the surface of all nucleated cells. 1. **Why Multiple Myeloma is correct:** In Multiple Myeloma (MM), there is a high turnover of plasma cells [1]. Since β2M is shed from the cell membrane into the serum, its levels correlate directly with the **total tumor burden** and the degree of renal dysfunction. It is the most important prognostic marker for MM and is a core component of the **International Staging System (ISS)**. High levels (>5.5 mg/L) indicate Stage III disease and a poorer prognosis. 2. **Why other options are incorrect:** * **Acute Lymphoblastic Leukemia (ALL):** While β2M can be elevated in various hematologic malignancies due to cell turnover, it is not used as a standard diagnostic or prognostic tumor marker for ALL. * **Hairy Cell Leukemia (HCL):** The primary markers for HCL are TRAP (Tartrate-Resistant Acid Phosphatase) and flow cytometry markers like CD103, CD11c, and CD25. * **Lymphoplasmacytic Lymphoma (Waldenström Macroglobulinemia):** While β2M can be elevated here, the hallmark marker is the **IgM monoclonal spike** [1]. It is not the primary marker used for clinical staging in the same way it is utilized in MM. **High-Yield Clinical Pearls for NEET-PG:** * **Prognosis:** In Multiple Myeloma, **Serum Albumin** (high is good) and **β2M** (low is good) are the two pillars of the ISS staging. * **Renal Link:** β2M is filtered by the glomerulus; therefore, its levels also rise in renal failure, which is a common complication of MM (Myeloma kidney) [2]. * **Other uses:** β2M is also used as a marker for monitoring **HIV progression** [2] and is associated with **Dialysis-related Amyloidosis** (Aβ2M type). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 606-609. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 607-608.

Question 624: Maximum increase in alpha-fetoprotein is seen with which condition?

A. Hepatocellular carcinoma (Correct Answer)
B. Benign mature teratoma
C. Choriocarcinoma
D. Teratoma

Explanation: **Explanation:** **Alpha-fetoprotein (AFP)** is a glycoprotein normally synthesized by the fetal liver and yolk sac. In adults, it serves as a critical tumor marker for specific malignancies. **Why Hepatocellular Carcinoma (HCC) is correct:** AFP is the most reliable serum marker for **Hepatocellular Carcinoma**. While it can be elevated in various liver pathologies (like cirrhosis or hepatitis), levels exceeding **400–500 ng/mL** are highly suggestive of HCC [1]. It is used for screening high-risk patients, diagnosis, and monitoring treatment response [1]. **Analysis of Incorrect Options:** * **Benign Mature Teratoma (Dermoid Cyst):** These are composed of well-differentiated mature tissues from all three germ layers. They are benign and typically **do not** secrete AFP. * **Choriocarcinoma:** This is a germ cell tumor characterized by the proliferation of cytotrophoblasts and syncytiotrophoblasts. Its hallmark marker is **beta-hCG**, not AFP. * **Teratoma:** While "Teratoma" is a broad term, immature teratomas or those with a **yolk sac component** can raise AFP. However, HCC remains the condition associated with the most significant and frequent "maximum" elevations in clinical practice. **High-Yield Clinical Pearls for NEET-PG:** * **Yolk Sac Tumor (Endodermal Sinus Tumor):** This is the other major condition where AFP is extremely high (often used as a diagnostic hallmark). * **AFP in Pregnancy:** Elevated levels in maternal serum are seen in **Neural Tube Defects** (e.g., Anencephaly, Spina Bifida), while decreased levels are associated with **Down Syndrome**. * **Non-seminomatous Germ Cell Tumors (NSGCT):** AFP is elevated in these, but **never** in pure Seminomas. * **Rule of Thumb:** If a question asks for a marker for HCC or Yolk Sac Tumor, think **AFP**. If it asks for Choriocarcinoma or Hydatidiform mole, think **hCG**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400.

Question 625: Which of the following malignancies shows rosette-shaped arrangement of cells in histology?

A. Thecoma of the ovary
B. Ependymoma (Correct Answer)
C. Neurofibroma
D. Lymphoma

Explanation: The correct answer is **Ependymoma**. In pathology, "rosettes" refer to a circular or spoke-like arrangement of cells around a central point. Ependymomas are classic examples of tumors that exhibit two specific types of rosette patterns [1]: 1. **Perivascular Pseudorosettes:** Tumor cells are arranged around a blood vessel, separated by a fibrillary zone (most common and diagnostic) [1]. 2. **True Ependymal Rosettes:** Tumor cells are arranged around a central lumen or canal (resembling the neural tube) [1]. **Analysis of Incorrect Options:** * **A. Thecoma of the ovary:** These are sex cord-stromal tumors characterized by spindle-shaped cells with lipid-laden cytoplasm. They do not form rosettes. * **C. Neurofibroma:** These are peripheral nerve sheath tumors composed of a mixture of Schwann cells, fibroblasts, and perineural cells in a loose collagenous stroma (shredded-carrot appearance). They lack rosette formations. * **D. Lymphoma:** Histologically, lymphomas typically show a diffuse sheet-like infiltration of monomorphic lymphoid cells. They do not form organized architectural patterns like rosettes. **High-Yield Clinical Pearls for NEET-PG:** * **Homer-Wright Rosettes:** Characterized by a central fibrillar (neuropil) core without a lumen. Seen in **Neuroblastoma**, **Medulloblastoma**, and **Retinoblastoma**. * **Flexner-Wintersteiner Rosettes:** Characterized by a central lumen. Highly specific for **Retinoblastoma**. * **Ependymoma Location:** In children, they typically occur in the **fourth ventricle** (leading to hydrocephalus); in adults, they are most common in the **spinal cord**. [1] * **Rod-shaped Blepharoplasts:** Basal bodies of cilia seen on electron microscopy in Ependymomas. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1312-1313.

Question 626: Low dietary fiber intake is related to which carcinoma?

A. Breast
B. Lung
C. Kidney
D. Colon (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Colon** The association between low dietary fiber and **Colorectal Carcinoma** [1] is a classic concept in oncology. The underlying medical mechanism involves several factors: 1. **Increased Transit Time:** Fiber increases stool bulk and decreases "fecal transit time." A low-fiber diet allows stool to remain in contact with the colonic mucosa for longer periods [1]. 2. **Dilution of Carcinogens:** Fiber dilutes potential dietary carcinogens and bile acid metabolites (like lithocholic acid) that can promote tumor growth [1]. 3. **Fermentation:** Gut bacteria ferment fiber into **Short-Chain Fatty Acids (SCFAs)** like butyrate, which have protective, anti-inflammatory, and pro-apoptotic effects on colonocytes. **Analysis of Incorrect Options:** * **A. Breast:** While high fat intake and obesity are risk factors for breast cancer (due to peripheral estrogen conversion), dietary fiber does not have a primary direct causal link. * **B. Lung:** The primary risk factors are tobacco smoke, radon, and asbestos. Diet plays a negligible role compared to inhaled carcinogens. * **C. Kidney:** Renal Cell Carcinoma is strongly associated with smoking, obesity, hypertension, and acquired cystic kidney disease, but not specifically with fiber intake. **NEET-PG High-Yield Pearls:** * **Protective Factors for Colon Cancer:** High fiber, antioxidants (Vitamins A, C, E), and NSAIDs (aspirin inhibits COX-2, which is overexpressed in many colon cancers). * **Risk Factors:** High intake of refined carbohydrates and red meat (heme iron and heterocyclic amines) [1]. * **Molecular Pathways:** Remember the **APC-β-catenin pathway** (Chromosomal instability) and the **Microsatellite Instability (MSI) pathway** (DNA mismatch repair genes). * **Most Common Site:** Historically the rectum/sigmoid, but there is a rising incidence of right-sided (proximal) colon cancers. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 817-819.

Question 627: Which of the following malignancies is associated with a BRAF gene mutation?

A. Breast carcinoma
B. Melanoma (Correct Answer)
C. Osteosarcoma
D. Prostate carcinoma

Explanation: **Explanation:** **BRAF** is a proto-oncogene that encodes a serine/threonine protein kinase involved in the **MAPK/ERK signaling pathway**, which regulates cell growth and proliferation [1]. The most common mutation is **V600E** (substitution of valine by glutamic acid at codon 600). 1. **Why Melanoma is Correct:** Approximately **40-60% of cutaneous melanomas** harbor a BRAF mutation [1]. This mutation leads to constitutive activation of the downstream signaling pathway, driving uncontrolled melanocyte proliferation [1]. It is a critical therapeutic target; BRAF inhibitors like **Vemurafenib** and **Dabrafenib** are standard treatments for BRAF-mutant metastatic melanoma [1]. 2. **Why Other Options are Incorrect:** * **Breast Carcinoma:** Primarily associated with mutations in **BRCA1/BRCA2**, TP53, or amplification of **HER2/neu**. * **Osteosarcoma:** Characterized by complex karyotypes, most commonly involving mutations in tumor suppressor genes **RB1** (Retinoblastoma) and **TP53** (Li-Fraumeni syndrome). * **Prostate Carcinoma:** Frequently associated with **TMPRSS2-ERG** gene fusions and PTEN deletions, rather than BRAF mutations. **High-Yield Clinical Pearls for NEET-PG:** * **Other BRAF-associated tumors:** Papillary Thyroid Carcinoma (most common mutation), Hairy Cell Leukemia (nearly 100% frequency), and Colon Adenocarcinoma (indicates poor prognosis). * **Zebra Sign:** In Hairy Cell Leukemia, BRAF V600E is a diagnostic hallmark. * **Pathway:** BRAF is a part of the **RAS-RAF-MEK-ERK** pathway [1]. * **Therapeutic Note:** BRAF inhibitors are often combined with MEK inhibitors (e.g., Trametinib) to prevent acquired resistance. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, pp. 1150-1153.

Question 628: Tumor-containing cells of all three germ layers are called?

A. Leiomyoma
B. Squamous cell carcinoma
C. Adenocarcinoma
D. Teratoma (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Teratoma** **Concept:** A **Teratoma** is a germ cell tumor composed of tissues derived from more than one germ cell layer—and typically all three: **ectoderm, mesoderm, and endoderm** [1]. These tumors arise from totipotent germ cells (usually found in the ovaries or testes) that have the capacity to differentiate into any cell type found in the adult body [1], [2]. * **Ectodermal elements:** Skin, hair follicles, brain tissue [1], [4]. * **Mesodermal elements:** Muscle, bone, cartilage, fat [2]. * **Endodermal elements:** Gut epithelium, thyroid tissue, respiratory lining [2]. **Analysis of Incorrect Options:** * **A. Leiomyoma:** A benign tumor arising from smooth muscle cells. It is derived from a single germ layer (**mesoderm**) and is monoclonal in origin. * **B. Squamous cell carcinoma:** A malignant epithelial tumor showing squamous differentiation. It is derived from a single germ layer (**ectoderm or endoderm**, depending on the site). * **C. Adenocarcinoma:** A malignant tumor of glandular epithelium. Like squamous cell carcinoma, it originates from a single germ layer. **NEET-PG High-Yield Pearls:** 1. **Classification:** Teratomas are classified as **Mature** (well-differentiated, usually benign in females) or **Immature** (contains fetal/neuroepithelial tissue, potentially malignant). 2. **Monodermal Teratoma:** A specialized teratoma composed of only one tissue type. Examples include **Struma ovarii** (thyroid tissue) and **Carcinoid** [3]. 3. **Dermoid Cyst:** The most common type of mature cystic teratoma, typically found in the ovary [1], [3]. 4. **Common Sites:** Sacrococcygeal region (most common in neonates), ovaries, and testes [5]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Female Genital Tract Disease, pp. 480-481. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1033-1034. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, p. 1034. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 276. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 979-980.

Question 629: Burkitt's Lymphoma is associated with which of the following viruses?

A. EBV (Epstein-Barr Virus) (Correct Answer)
B. HTLV-1 (Human T-lymphotropic virus 1)
C. HHV-8 (Human herpesvirus 8)
D. Adenovirus

Explanation: **Explanation:** **Burkitt’s Lymphoma (BL)** is a highly aggressive B-cell non-Hodgkin lymphoma strongly associated with the **Epstein-Barr Virus (EBV)** [1]. The association is most profound in the **Endemic (African) variant**, where EBV is found in nearly 100% of cases [2]. The virus infects B-cells, leading to polyclonal proliferation, which increases the risk of a specific chromosomal translocation: **t(8;14)**. This translocation moves the **c-MYC oncogene** to the immunoglobulin heavy chain (IgH) locus, resulting in constitutive expression of MYC, a potent driver of cell proliferation and metabolism. **Analysis of Incorrect Options:** * **HTLV-1:** This retrovirus is the causative agent of **Adult T-cell Leukemia/Lymphoma (ATLL)**, characterized by flower-shaped cells and hypercalcemia [1]. * **HHV-8:** Also known as Kaposi Sarcoma-associated Herpesvirus (KSHV), it is linked to **Kaposi Sarcoma** and **Primary Effusion Lymphoma (PEL)** [1], [3]. * **Adenovirus:** While used in gene therapy vectors and known for causing respiratory/conjunctival infections, it is not oncogenic in humans. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** Classic **"Starry-sky appearance"** on histology (tingible body macrophages against a background of dark neoplastic B-cells). * **Genetics:** t(8;14) is most common; t(2;8) and t(8;22) are variants involving light chains. * **Clinical Presentation:** Endemic BL typically involves the **jaw/mandible**, whereas Sporadic BL (less associated with EBV) often involves the **ileocecal region** [4]. * **Cell Markers:** CD19, CD20, CD10, and BCL6 positive; notably **BCL2 negative**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 219-220. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 335-336. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 261-262. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 220-221.

Question 630: Which of the following is NOT a tumor suppressor gene?

A. WT-1
B. Rb
C. p53
D. RAS (Correct Answer)

Explanation: **Explanation:** The fundamental distinction in cancer genetics lies between **Proto-oncogenes** (which promote cell growth) and **Tumor Suppressor Genes (TSGs)** (which inhibit cell growth) [2]. **Why RAS is the correct answer:** **RAS** is a classic example of a **proto-oncogene**. It encodes a membrane-associated G-protein involved in signal transduction. When mutated (most commonly at codons 12, 13, or 61), it becomes constitutively active, leading to continuous cell proliferation signals. It is the most common oncogene abnormality in human tumors (especially pancreatic and colon cancers). **Why the other options are incorrect:** * **WT-1 (Wilms Tumor 1):** A TSG located on chromosome 11p13. It is essential for normal renal and gonadal development; its inactivation leads to Wilms tumor. * **Rb (Retinoblastoma gene):** Known as the "Governor of the Cell Cycle," it is a TSG on chromosome 13q14 [3]. It controls the G1 to S phase transition by sequestering the E2F transcription factor [2]. * **p53 (TP53):** Known as the "Guardian of the Genome," it is the most frequently mutated gene in human cancer [4]. It acts as a TSG by inducing cell cycle arrest, DNA repair, or apoptosis in response to DNA damage [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Knudson’s "Two-Hit" Hypothesis:** Applies to TSGs (both alleles must be inactivated), whereas oncogenes require only a "single hit" (gain-of-function mutation) [1]. * **RAS Mutation:** Associated with **GTPase-activating protein (GAP)** failure; the RAS protein remains trapped in the active GTP-bound state. * **Li-Fraumeni Syndrome:** Germline mutation of **p53**, leading to multiple primary tumors. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228.

Practice by Chapter

Nomenclature and Classification of Tumors

Practice Questions

Characteristics of Benign and Malignant Neoplasms

Practice Questions

Molecular Basis of Cancer

Practice Questions

Carcinogenesis and Carcinogens

Practice Questions

Tumor Progression and Metastasis

Practice Questions

Tumor Markers

Practice Questions

Paraneoplastic Syndromes

Practice Questions

Genetic Basis of Cancer

Practice Questions

Tumor Immunity

Practice Questions

Cancer Epidemiology and Prevention

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Neoplasia — MCQs

Neoplasia — MCQs

On this page

Practice by Chapter

Want unlimited practice?